The role of fluoroquinolones in respiratory tract infections

R F Grossman1

  • 1Division of Respiratory Medicine, Mount Sinai Hospital, Toronto, Canada.

Insights

Quinolones are effective antibiotics for various infections, including otitis media and bronchitis. Despite some reluctance for respiratory infections, they show comparable efficacy to other treatments and are valuable for severe pneumonia and switch therapy.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Antimicrobial Therapy

Background:

  • Quinolones are widely accepted for treating infections due to favorable pharmacokinetics, high antimicrobial activity, and low side-effect incidence.
  • Despite their benefits, reluctance exists in using quinolones for respiratory tract infections due to perceived limitations against Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus.

Purpose of the Study:

  • To evaluate the efficacy and application of quinolones in treating various bacterial infections.
  • To address the reluctance in using quinolones for specific indications like respiratory tract infections and sinusitis.
  • To review the role of quinolones in managing community-acquired and hospital-acquired pneumonia.

Main Methods:

  • Review of existing literature and clinical guidelines regarding quinolone use.
  • Comparison of quinolone efficacy against other antibiotic classes (beta-lactams, cephalosporins) in different infections.
  • Analysis of quinolone application in specific conditions such as malignant external otitis, chronic otitis media, sinusitis, bronchitis, and pneumonia.

Main Results:

  • Ciprofloxacin is effective for malignant external otitis and chronic otitis media caused by Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis.
  • Quinolones demonstrate equivalent efficacy to beta-lactams and cephalosporins in acute sinusitis and acute bacterial exacerbations of chronic bronchitis.
  • Current guidelines recommend quinolones for severe community-acquired pneumonia and hospital-acquired pneumonia, often in combination therapy, and support early switch to oral fluoroquinolones.

Conclusions:

  • Quinolones are highly effective and versatile antimicrobials with a broad spectrum of activity.
  • Their use in respiratory tract infections and sinusitis is supported by evidence of efficacy comparable to standard treatments.
  • Quinolones play a crucial role in managing severe pneumonia and facilitate successful early switch therapy from parenteral to oral administration.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...